1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Microneedles and Needle-Free Injection Systems Revenue
1.4 Market Analysis by Type
1.4.1 Global Microneedles and Needle-Free Injection Systems Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Disposable Use
1.4.3 Re-usable Use
1.5 Market by Application
1.5.1 Global Microneedles and Needle-Free Injection Systems Market Share by Application: 2021-2026
1.5.2 Infectious Disease
1.5.3 Osteoarthritis
1.5.4 Painful Disease
1.5.5 Cancer
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Microneedles and Needle-Free Injection Systems Market
1.8.1 Global Microneedles and Needle-Free Injection Systems Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Microneedles and Needle-Free Injection Systems Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Microneedles and Needle-Free Injection Systems Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Microneedles and Needle-Free Injection Systems Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Microneedles and Needle-Free Injection Systems Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Microneedles and Needle-Free Injection Systems Sales Volume Market Share by Region (2015-2020)
3.2 Global Microneedles and Needle-Free Injection Systems Sales Revenue Market Share by Region (2015-2020)
3.3 North America Microneedles and Needle-Free Injection Systems Sales Volume
3.3.1 North America Microneedles and Needle-Free Injection Systems Sales Volume Growth Rate (2015-2020)
3.3.2 North America Microneedles and Needle-Free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Microneedles and Needle-Free Injection Systems Sales Volume
3.4.1 East Asia Microneedles and Needle-Free Injection Systems Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Microneedles and Needle-Free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Microneedles and Needle-Free Injection Systems Sales Volume (2015-2020)
3.5.1 Europe Microneedles and Needle-Free Injection Systems Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Microneedles and Needle-Free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Microneedles and Needle-Free Injection Systems Sales Volume (2015-2020)
3.6.1 South Asia Microneedles and Needle-Free Injection Systems Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Microneedles and Needle-Free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Microneedles and Needle-Free Injection Systems Sales Volume (2015-2020)
3.7.1 Southeast Asia Microneedles and Needle-Free Injection Systems Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Microneedles and Needle-Free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Microneedles and Needle-Free Injection Systems Sales Volume (2015-2020)
3.8.1 Middle East Microneedles and Needle-Free Injection Systems Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Microneedles and Needle-Free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Microneedles and Needle-Free Injection Systems Sales Volume (2015-2020)
3.9.1 Africa Microneedles and Needle-Free Injection Systems Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Microneedles and Needle-Free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Microneedles and Needle-Free Injection Systems Sales Volume (2015-2020)
3.10.1 Oceania Microneedles and Needle-Free Injection Systems Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Microneedles and Needle-Free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Microneedles and Needle-Free Injection Systems Sales Volume (2015-2020)
3.11.1 South America Microneedles and Needle-Free Injection Systems Sales Volume Growth Rate (2015-2020)
3.11.2 South America Microneedles and Needle-Free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Microneedles and Needle-Free Injection Systems Sales Volume (2015-2020)
3.12.1 Rest of the World Microneedles and Needle-Free Injection Systems Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Microneedles and Needle-Free Injection Systems Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Microneedles and Needle-Free Injection Systems Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Microneedles and Needle-Free Injection Systems Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Microneedles and Needle-Free Injection Systems Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Microneedles and Needle-Free Injection Systems Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Microneedles and Needle-Free Injection Systems Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Microneedles and Needle-Free Injection Systems Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Microneedles and Needle-Free Injection Systems Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Microneedles and Needle-Free Injection Systems Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Microneedles and Needle-Free Injection Systems Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Microneedles and Needle-Free Injection Systems Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Microneedles and Needle-Free Injection Systems Sales Volume Market Share by Type (2015-2020)
14.2 Global Microneedles and Needle-Free Injection Systems Sales Revenue Market Share by Type (2015-2020)
14.3 Global Microneedles and Needle-Free Injection Systems Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Microneedles and Needle-Free Injection Systems Consumption Volume by Application (2015-2020)
15.2 Global Microneedles and Needle-Free Injection Systems Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Microneedles and Needle-Free Injection Systems Business
16.1 Inovio Pharmaceuticals
16.1.1 Inovio Pharmaceuticals Company Profile
16.1.2 Inovio Pharmaceuticals Microneedles and Needle-Free Injection Systems Product Specification
16.1.3 Inovio Pharmaceuticals Microneedles and Needle-Free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Valeritas
16.2.1 Valeritas Company Profile
16.2.2 Valeritas Microneedles and Needle-Free Injection Systems Product Specification
16.2.3 Valeritas Microneedles and Needle-Free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 D'Antonio Consultants International
16.3.1 D'Antonio Consultants International Company Profile
16.3.2 D'Antonio Consultants International Microneedles and Needle-Free Injection Systems Product Specification
16.3.3 D'Antonio Consultants International Microneedles and Needle-Free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 3M
16.4.1 3M Company Profile
16.4.2 3M Microneedles and Needle-Free Injection Systems Product Specification
16.4.3 3M Microneedles and Needle-Free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Inolife Sciences
16.5.1 Inolife Sciences Company Profile
16.5.2 Inolife Sciences Microneedles and Needle-Free Injection Systems Product Specification
16.5.3 Inolife Sciences Microneedles and Needle-Free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Medical International Technology
16.6.1 Medical International Technology Company Profile
16.6.2 Medical International Technology Microneedles and Needle-Free Injection Systems Product Specification
16.6.3 Medical International Technology Microneedles and Needle-Free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Micropoint Technologies
16.7.1 Micropoint Technologies Company Profile
16.7.2 Micropoint Technologies Microneedles and Needle-Free Injection Systems Product Specification
16.7.3 Micropoint Technologies Microneedles and Needle-Free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 PharmaJet
16.8.1 PharmaJet Company Profile
16.8.2 PharmaJet Microneedles and Needle-Free Injection Systems Product Specification
16.8.3 PharmaJet Microneedles and Needle-Free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Enesi Pharma
16.9.1 Enesi Pharma Company Profile
16.9.2 Enesi Pharma Microneedles and Needle-Free Injection Systems Product Specification
16.9.3 Enesi Pharma Microneedles and Needle-Free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 NanoPass Technologies
16.10.1 NanoPass Technologies Company Profile
16.10.2 NanoPass Technologies Microneedles and Needle-Free Injection Systems Product Specification
16.10.3 NanoPass Technologies Microneedles and Needle-Free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Nemaura Pharma
16.11.1 Nemaura Pharma Company Profile
16.11.2 Nemaura Pharma Microneedles and Needle-Free Injection Systems Product Specification
16.11.3 Nemaura Pharma Microneedles and Needle-Free Injection Systems Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Microneedles and Needle-Free Injection Systems Manufacturing Cost Analysis
17.1 Microneedles and Needle-Free Injection Systems Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Microneedles and Needle-Free Injection Systems
17.4 Microneedles and Needle-Free Injection Systems Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Microneedles and Needle-Free Injection Systems Distributors List
18.3 Microneedles and Needle-Free Injection Systems Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Microneedles and Needle-Free Injection Systems (2021-2026)
20.2 Global Forecasted Revenue of Microneedles and Needle-Free Injection Systems (2021-2026)
20.3 Global Forecasted Price of Microneedles and Needle-Free Injection Systems (2015-2026)
20.4 Global Forecasted Production of Microneedles and Needle-Free Injection Systems by Region (2021-2026)
20.4.1 North America Microneedles and Needle-Free Injection Systems Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Microneedles and Needle-Free Injection Systems Production, Revenue Forecast (2021-2026)
20.4.3 Europe Microneedles and Needle-Free Injection Systems Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Microneedles and Needle-Free Injection Systems Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Microneedles and Needle-Free Injection Systems Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Microneedles and Needle-Free Injection Systems Production, Revenue Forecast (2021-2026)
20.4.7 Africa Microneedles and Needle-Free Injection Systems Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Microneedles and Needle-Free Injection Systems Production, Revenue Forecast (2021-2026)
20.4.9 South America Microneedles and Needle-Free Injection Systems Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Microneedles and Needle-Free Injection Systems Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Microneedles and Needle-Free Injection Systems by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Microneedles and Needle-Free Injection Systems by Country
21.2 East Asia Market Forecasted Consumption of Microneedles and Needle-Free Injection Systems by Country
21.3 Europe Market Forecasted Consumption of Microneedles and Needle-Free Injection Systems by Countriy
21.4 South Asia Forecasted Consumption of Microneedles and Needle-Free Injection Systems by Country
21.5 Southeast Asia Forecasted Consumption of Microneedles and Needle-Free Injection Systems by Country
21.6 Middle East Forecasted Consumption of Microneedles and Needle-Free Injection Systems by Country
21.7 Africa Forecasted Consumption of Microneedles and Needle-Free Injection Systems by Country
21.8 Oceania Forecasted Consumption of Microneedles and Needle-Free Injection Systems by Country
21.9 South America Forecasted Consumption of Microneedles and Needle-Free Injection Systems by Country
21.10 Rest of the world Forecasted Consumption of Microneedles and Needle-Free Injection Systems by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer